We studied the efficacy and pharmacokinetics of intraventricularly administered vancomycin in three patients with shunt-associated staphylococcal ventriculitis. We instilled 10 mg of the drug intraventricularly every 24 hours. Cerebrospinal fluid (CSF) levels were measured 1 hour after instillation and then every 2 hours. Peak vancomycin levels reached a mean of 292.9 mg/mL. The mean trough levels, measured immediately before readministration of vancomycin, were 7.6 mg/ mL; this level has proved to be sufficient for maintaining the necessary steady-state serum concentration of vancomycin. All three patients were cured clinically and bacteriologically, and CSF parameters returned to normal within 5 -13 days. No side effects were observed. Our results suggest that intraventricularly administered vancomycin is a valuable therapeutic strategy for treating shuntassociated staphylococcal ventriculitis. In addition, we provide evidence that 10 mg of vancomycin, administered intraventricularly every 24 hours, allows maintenance of therapeutic drug levels in the CSF for at least 24 hours.
Infection is a major complication and cause of failure of age because of the onset of obstructive hydrocephalus. Both patients with tuberculous meningitis had a relapse of ventricu-CSF shunting devices used to control hydrocephalus; the incidence of this complication ranges from 1% to 39% [1] . External loperitoneal shunt -associated staphylococcal ventriculitis after they received intravenous vancomycin therapy. The third paventricular drainage, used as a temporary tool to control acute obstructive hydrocephalus that leads to raised intracranial prestient had severe trauma-related intraventricular hemorrhage, trauma-related multiorgan failure, and external shunt -associsure, is similarly, if not more frequently, associated with ascending infection resulting in ventriculitis [1] . The organisms ated staphylococcal ventriculitis. As CSF cultures for all patients yielded highly resistant staphylococci, the intraventricuinvolved are predominantly gram positives, and coagulasenegative staphylococci are the most common [1, 2] . In general, lar administration of vancomycin was considered inevitable and least dangerous. Ten milligrams of vancomycin, at a constaphylococcal ventriculitis associated with a permanent shunt necessitates removal of the shunt [2] . centration of 1,000 mg/mL, was instilled via an external drain, which was then flushed with 2 mL of NaCl [6] and clamped Several investigators have reported the partially successful intraventricular administration of vancomycin in varying dosfor 1 hour. Vancomycin levels were measured immediately before (re)instillation and every 2 hours thereafter. The therapy age regimens [1, 3 -5] . However, little is known about the drug's pharmacokinetics, potential accumulation, and toxic levwas continued until apparent cure was achieved. Measurements were performed by using a fluorescence polarization immunoels in human CSF [3] . We describe three patients who developed staphylococcal ventriculitis that was treated successfully assay (TDx/TDxFLx vancomycin; Abbott, Vienna, Austria) after centrifugation (2.123g for 7 minutes at 14 { 5ЊC) [7, 8] . with intraventricular vancomycin. CSF levels were measured every 2 hours, and these measurements provided actual intraFinally, the means { SDs of the corresponding levels were calculated. ventricular pharmacokinetic data.
Patients and Methods
Results Two patients with tuberculous meningitis and one patient Methicillin-resistant Staphylococcus aureus (MRSA) was with severe traumatic brain injury required external CSF drainidentified as the cause of drain-associated ventriculitis in all three patients; the first patient was cured by intraventricular administration of 10 mg of vancomycin after 5 days, the second was cured after 8 days, and the third was cured after 13 days. CSF culture) was achieved within 1 -3 days, whereas normalInformation about the pharmacokinetics of vancomycin and ization of CSF parameters took 5 -11 days.
their clinical and bacteriologic implications in patients with shunt device -associated ventriculitis is insufficient and conflicting. Most of the data available so far have been collected Discussion in cases of aresorptive hydrocephalus. Even less is known in the case of obstructive hydrocephalus, where the CSF circulation is Vancomycin is highly efficacious against coagulase-negative more profoundly altered. In two of our patients, severe tubercustaphylococci, the main causative agents of shunt-and drainlous meningitis leading to obstructive hydrocephalus necessirelated ventriculitis. Vancomycin is therefore a valuable drug tated the implantation of a ventriculoperitoneal shunt. The for treatment of implant device -associated infections. Howshunt-associated ventriculitis that they developed could not be ever, therapeutic CSF levels are difficult to achieve in patients contained by intravenous antibiotic therapy. The shunting with staphylococcal ventriculitis because the usually mild, devices were removed, and within a few days, the onset of acute inflammatory response of the meninges results in poor severe hydrocephalus prompted immediate external ventricular penetration of vancomycin through the blood-brain barrier.
drainage. Bayston et al. [1] treated 18 of 33 patients with ventriculitis At this time, ventricular CSF samples still showed signs of successfully with intraventricular vancomycin; these patients inflammation, and ventricular CSF cultures were positive for had had unfavorable courses when they were treated intrave-MRSA. Consequently, intraventricular administration of vannously. Moreover, it has been reported that CSF levels of vancomycin was initiated. No drug accumulation was observed comycin never rose above 6 mg/mL after intravenous adminiswith peak dose levels (C max ), ranging from a minimum of 72.2 tration [3] . In contrast, when vancomycin was given mg/mL (day 4 for patient 1) to 812.6 mg/mL (day 7 for patient intraventricularly, CSF levels were found to be as high as 100
2). However, the predose levels (C min ) always decreased to mg/mL [4] . In addition, Arroyo and Quindlen [4] observed an õ20 mg/mL, even when peak levels of ú800 mg/mL had been accumulation of vancomycin throughout a period of 9 days, measured. Therefore, the notion of drug accumulation reaching rising from 70 mg/mL after the first dose to 606 mg/mL after potentially toxic levels [4] has to be reconsidered. the ninth day. It is important to note that no side effects were Therapeutically effective mean steady-state serum concenseen in these patients.
trations of vancomycin range from 15 mg/mL to 40 mg/mL [5, Although an empirical intraventricular dose (10 -20 mg) of 10]. For all three of our patients, both bacteriologic clearance vancomycin, given every 24 hours, is recommended, very little and clinical cure were achieved with mean trough CSF levels is known about the pharmacokinetics of the drug when it is of 7.6 mg/mL (dose, 10 mg of vancomycin every day). This administered via this route [9] . Arroyo and Quindlen [4] and level lies exactly within the level range of 5 -10 mg/mL that Reesor et al. [5] have measured CSF levels once and twice is needed to maintain a mean steady-state serum concentration daily in patients receiving intraventricular vancomycin therapy.
of Ç15 mg/mL as recommended by Cooper and Given [3] . As Ressor et al. found a doubling of the elimination half-life of vancomycin after 24 hours of therapy [5] .
we found, this concentration has already been shown to corre-
